Capital Management Corp VA Increases Stake in CME Group Inc. $CME

Capital Management Corp VA increased its position in shares of CME Group Inc. (NASDAQ:CME) by 15.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 35,187 shares of the financial services provider’s stock after purchasing an additional 4,780 shares during the period. CME Group makes up 1.5% of Capital Management Corp VA’s portfolio, making the stock its 26th largest holding. Capital Management Corp VA’s holdings in CME Group were worth $9,507,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in CME. Empowered Funds LLC boosted its position in shares of CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares during the period. Capital Investment Advisors LLC bought a new stake in shares of CME Group during the 2nd quarter worth approximately $211,000. Truist Financial Corp boosted its holdings in CME Group by 10.0% during the 2nd quarter. Truist Financial Corp now owns 64,939 shares of the financial services provider’s stock valued at $17,898,000 after acquiring an additional 5,914 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its position in CME Group by 22.4% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 81,446 shares of the financial services provider’s stock valued at $22,448,000 after acquiring an additional 14,921 shares during the last quarter. Finally, Exchange Capital Management Inc. increased its stake in CME Group by 1.4% in the second quarter. Exchange Capital Management Inc. now owns 3,771 shares of the financial services provider’s stock worth $1,039,000 after purchasing an additional 52 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Transactions at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ CME opened at $289.06 on Friday. The company has a market cap of $104.24 billion, a PE ratio of 28.01, a P/E/G ratio of 3.26 and a beta of 0.27. The firm’s 50 day moving average price is $275.25 and its 200-day moving average price is $272.33. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $233.66 and a 52-week high of $291.76.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were issued a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CME shares. Weiss Ratings reissued a “buy (b+)” rating on shares of CME Group in a research note on Monday, December 29th. Royal Bank Of Canada lifted their price objective on shares of CME Group from $282.00 to $295.00 and gave the company a “sector perform” rating in a report on Friday, December 5th. UBS Group restated a “neutral” rating on shares of CME Group in a research note on Tuesday, January 6th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a research report on Thursday, January 22nd. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $292.18.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.